Budget Impact and Cost-Effectiveness of Intravenous Meloxicam to Treat Moderate–Severe Postoperative Pain
Crossref DOI link: https://doi.org/10.1007/s12325-022-02174-6
Published Online: 2022-06-09
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carter, John A.
Black, Libby K.
Deering, Kathleen L.
Jahr, Jonathan S.
Funding for this research was provided by:
Baudax Bio, Inc
Text and Data Mining valid from 2022-06-09
Version of Record valid from 2022-06-09
Article History
Received: 2 March 2022
Accepted: 26 April 2022
First Online: 9 June 2022